InvestorsHub Logo
Followers 826
Posts 119467
Boards Moderated 15
Alias Born 09/05/2002

Re: None

Friday, 04/15/2016 8:26:46 AM

Friday, April 15, 2016 8:26:46 AM

Post# of 2933
Impressive ABBV/ENTA SVR rates for ABT-493/ABT-450 in patients who failed prior all-DAA therapy:

http://finance.yahoo.com/news/enanta-announces-abbvie-investigational-pan-051500346.html


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENTA News